Press Releases Filter Filter Results Year 2025 (2) 2024 (5) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (24) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) March 19, 2017 First-Ever Presentation on Abiomed's Impella® Quality (IQ) Assurance Program and Importance of Treatment Protocols to Improve Patient Survival and Heart Recovery at the 2017 American College of Cardiology Scientific Session March 16, 2017 Abiomed's Impella® Technology Showcased at 2017 American College of Cardiology Scientific Session With More Than 10 Presentations March 9, 2017 New Study Finds Abiomed Impella® Heart Pump Reduces Injury to Kidneys During High-Risk Percutaneous Coronary Intervention February 23, 2017 Abiomed Surpasses 50,000 Impella® Patients Treated in the United States February 21, 2017 Abiomed Celebrates 2017 American Heart Month January 26, 2017 Abiomed Announces Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year January 9, 2017 Abiomed Announces Preliminary Q3 FY 2017 Revenue of $114.7 Million, Up 34% Over Prior Year January 5, 2017 Abiomed Third Quarter Fiscal 2017 Earnings and Conference Call Notification December 27, 2016 Abiomed to Present at the 35th Annual J.P. Morgan Healthcare Conference December 7, 2016 Abiomed Impella CP Receives Expanded FDA Approval for High-Risk Percutaneous Coronary Intervention (PCI) Procedures October 31, 2016 Abiomed Launches Impella Quality (IQ) Assurance Program and Shares Insight From Largest Database of Real-World Evidence of High-Risk PCI and Cardiogenic Shock Patients October 27, 2016 Abiomed Announces Q2 FY 2017 Revenue of $103 Million, Up 35% Over Prior Year October 27, 2016 Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study October 25, 2016 Abiomed's Impella Technology Showcased at TCT 2016 With More Than 25 Presentations During Scientific Sessions October 6, 2016 Abiomed Second Quarter Fiscal 2017 Earnings and Conference Call Notification … 11 12 13 14 …
